Recce Pharmaceuticals and its Board of Directors are committed to achieving and implementing effective corporate governance practises to ensure the organisation is managed in an effective, transparent and ethical manner.

The Company continues to monitor and report against current ASX Corporate Governance Principles and Recommendations.

Follow this link to read the Corporate Governance Statement from Recce's Annual Report.

Follow this link to read the Company's Constitution.

Recce Pharmaceuticals follows good corporate governance practices, which include the adoption of committees to provide advice to the full board.

Recce’s two committees are the:

Nomination and Remuneration Committee - responsible for evaluating the performance of the Board and individual Directors on a quarterly basis.

Audit and Risk Committee Management Committee - responsible for the robustness of the various internal control systems it has in place to safeguard the integrity of the company’s financial reporting.

Details of the committees and company charters:

• Board Charter
• Company Code of Conduct
• Audit & Risk Management Committee Charter
• Nomination & Remuneration Committee Charter
• Notice of 2020 Annual General Meeting

Policies - Please see below a list of Recce's policies:.

• Trading Policy
• Diversity Policy
• Continuous Disclosure Policy
• Shareholder Communication Strategy
• Risk Management Policy